药物的手表。管道进展:过去和现在。

BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation Pub Date : 2005-01-01

John Hawes

{"title":"药物的手表。管道进展:过去和现在。","authors":"John Hawes","doi":"","DOIUrl":null,"url":null,"abstract":"The antiretroviral drug pipeline was last reviewed in BETA three years ago (see \"The HIV/AIDS drug pipeline: a status report\" in the Summer/Autumn 2002 issue). That report called on pharmaceutical companies to \"ensure a steadier stream of innovative and affordable approaches to managing HIV infection.\" Is this goal being achieved?","PeriodicalId":80644,"journal":{"name":"BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation","volume":"17 4","pages":"15-7"},"PeriodicalIF":0.0000,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Drug watch. Pipeline progress: then and now.\",\"authors\":\"John Hawes\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The antiretroviral drug pipeline was last reviewed in BETA three years ago (see \\\"The HIV/AIDS drug pipeline: a status report\\\" in the Summer/Autumn 2002 issue). That report called on pharmaceutical companies to \\\"ensure a steadier stream of innovative and affordable approaches to managing HIV infection.\\\" Is this goal being achieved?\",\"PeriodicalId\":80644,\"journal\":{\"name\":\"BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation\",\"volume\":\"17 4\",\"pages\":\"15-7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

《BETA》上一次审查抗逆转录病毒药物管道是在三年前(见2002年夏/秋期的“艾滋病毒/艾滋病药物管道:现状报告”)。该报告呼吁制药公司“确保有更稳定的创新和负担得起的方法来控制艾滋病毒感染。”这个目标实现了吗?

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

Drug watch. Pipeline progress: then and now.

The antiretroviral drug pipeline was last reviewed in BETA three years ago (see "The HIV/AIDS drug pipeline: a status report" in the Summer/Autumn 2002 issue). That report called on pharmaceutical companies to "ensure a steadier stream of innovative and affordable approaches to managing HIV infection." Is this goal being achieved?

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation

自引率

0.00%

发文量